Analyst Information for ImmunoGen Inc.

$ 3.39   -0.09 (-2.59%) Volume: 2.12m 4:00 PM EDT Apr 7, 2020
After Hours:  $ 3.39 0.00 (0.00%) Volume: 22.46k 5:54 PM EDT Apr 7, 2020
Consensus Rating Average
Consensus Rating for IMGN is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.00
Previous Average Recommendation 2.43
Change in Average Recommendation -0.43
Number of Analysts Reporting 6
Strong Buy
1.0
Current: 2.00
Previous: 2.43
Change: -0.43
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-DRUGS
Number of companies in industry with recommendations 182
Rank Recommendation relative to companies in its industry 136
Ranked 136 in Industry
1182 MED-DRUGS
Analyst Recommendations
Analysts recommending Strong Buy 3
Analysts recommending Moderate Buy 0
Analysts recommending Hold 3
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 3 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
Mean Rec. 2.00 2.43 2.50 2.50

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.